Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

Recruiting

Trial ID: NCT00628199

Age - 1 Year-75 Years Gender - All Accepting Healthy Volunteers - yes

Purpose

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Official Title

Derivation of Primary Donor Cell Lines for Human Cell Reprogramming

Stanford Investigator(s)

Marius Wernig

Eligibility


Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders
such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian
failure)

Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin
biopsy sample due to skin condition in the underarm area.

View More
View Less

Intervention(s):

procedure: Improving the scientific process of human cell reprogramming

Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2024 Stanford Medicine